Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 330, Issue 2, 2009, Pages 370-376

  Wu, Shih Lu ^a   Chen, Jaw Chyun ^c   Li, Chia Cheng ^a   Lo, Hsin Yi ^a   Ho, Tin Yun ^a,b   Hsiang, Chien Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c DA YEH UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; SYNAPTOTAGMIN I; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; VANILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; ENZYME ACTIVATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

ANIMALS; BENZALDEHYDES; COLITIS; FEMALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; TRINITROBENZENESULFONIC ACID;

EID: 67651100698     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.152835     Document Type: Article

References (41)

1. Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, and Shirai T (1995) Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett 94:113-121.
2. Bantel H, Berg C, Vieth M, Stolte M, Kruis W, and Schulze-Osthoff K (2000) Mesalazine inhibits activation of transcription factor NF-κB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol 95:3452-3457.
3. Barnes PJ and Karin M (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071. (Pubitemid 27163860)
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Carlsen H, Moskaug JØ, Fromm SH, and Blomhoff R (2002) In vivo imaging of NF-κB activity. J Immunol 168:1441-1446.
6. Carlsen H, Alexander G, Austenaa LM, Ebihara K, and Blomhoff R (2004) Molecular imaging of the transcription factor NF-κB, a primary regulator of stress response. Mutat Res 551:199-211. (Pubitemid 38833508)
7. Cheng WY, Wu SL, Hsiang CY, Li CC, Lai TY, Lo HY, Shen WS, Lee CH, Chen JC, Wu HC, et al. (2008) Relationship between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells. Am J Chin Med 36:783-797.
8. Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458-466. (Pubitemid 351733422)
9. Economou M and Pappas G (2008) New global map of Crohn's disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis 14:709-720. (Pubitemid 351742998)
10. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, and McGhee JR (1996) Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol 157:2174-2185. (Pubitemid 126449698)
11. Fitzgerald DJ, Stratford M, Gasson MJ, Ueckert J, Bos A, and Narbad A (2004) Mode of antimicrobial action of vanillin against Escherichia coli, Lactobacillus plantarum and Listeria innocua. J Appl Microbiol 97:104-113. (Pubitemid 38869887)
12. Hagan EC, Hansen WH, Fitzhugh OG, Jenner PM, Jones WI, Taylor JM, Long EL, Nelson AA, and Brouwer JB (1967) Food flavourings and compounds of related structure. II. Subacute and chronic toxicity. Food Cosmet Toxicol 5:141-157.
13. Hanauer SB and Meyers S (1997) Management of Crohn's disease in adults. Am J Gastroenterol 92:559-566.
14. Ho TY, Chen YS, and Hsiang CY (2007) Noninvasive nuclear factor-κB bioluminescence imaging for the assessment of host-biomaterial interaction in transgenic mice. Biomaterials 28:4370-4377.
15. Hogaboam CM, Vallance BA, Kumar A, Addison CL, Graham FL, Gauldie J, and Collins SM (1997) Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest 100:2766-2776. (Pubitemid 28007545)
16. Holland N, Dong J, Garnett E, Shaikh N, Huen K, Harmatz P, Olive A, Winter HS, Gold BD, Cohen SA, et al. (2008) Reduced intracellular T-helper 1 interferon-γ in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles. Pediatr Res 63:257-262. (Pubitemid 351301453)
17. Hsiang CY, Wu SL, and Ho TY (2005) Morin inhibited 12-O- tetradecanoylphorbol- 13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. Biochem Pharmacol 69:1603-1611.
18. Ischiropoulos H, Zhu L, and Beckman JS (1992) Peroxynitrite formation from macrophage- derived nitric oxide. Arch Biochem Biophys 298:446-451.
19. Jansson T and Zech L (1987) Effects of vanillin on sister-chromatid exchanges and chromosome aberrations in human lymphocytes. Mutat Res 190:221-224. (Pubitemid 17020132)
20. Joshi R, Kumar S, Unnikrishnan M, and Mukherjee T (2005) Free radical scavenging reactions of sulfasalazine, 5-aminosalicylic acid and sulfapyridine: mechanistic aspects and antioxidant activity. Free Radic Res 39:1163-1172. (Pubitemid 41601418)
21. Kamat JP, Ghosh A, and Devasagayam TP (2000) Vanillin as an antioxidant in rat liver mitochondria: inhibition of protein oxidation and lipid peroxidation induced by photosensitization. Mol Cell Biochem 209:47-53. (Pubitemid 30451434)
22. Karin M and Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18:621-663. (Pubitemid 30365393)
23. Kirwin CJ and Galvin JB (1993) Ethers, in Patty's Industrial Hygiene and Toxicology (Clayton GD and Clayton FE eds) pp 445-525, John Wiley & Sons, New York.
24. Kruidenier L, Kuiper I, Lamers CB, and Verspaget HW (2003) Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 201:28-36. (Pubitemid 37121200)
25. Lee CH, Wu SL, Chen JC, Li CC, Lo HY, Cheng WY, Lin JG, Chang YH, Hsiang CY, and Ho TY (2008) Eriobotrya japonica leaf and its triterpenes inhibited lipopolysaccharide- induced cytokines and inducible enzyme production via the nuclear factor-κB signaling pathway in lung epithelial cells. Am J Chin Med 36:1185-1198.
26. Liang JA, Wu SL, Lo HY, Hsiang CY, and Ho TY (2009) Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-κB signaling pathway in human hepatocellular carcinoma cells. Mol Pharmacol 75:151-157.
27. Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo MK, Saitoh Y, Aozuka Y, Singhirunnusorn P, Ruchirawat S, Svasti J, and Saiki I (2005) Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells. Eur J Pharm Sci 25:57-65. (Pubitemid 40602196)
28. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, and Zeiger E (1986) Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ Mutagen 8:1-119. (Pubitemid 16084504)
29. Murakami Y, Hirata A, Ito S, Shoji M, Tanaka S, Yasui T, Machino M, and Fujisawa S (2007) Re-evaluation of cyclooxygenase-2-inhibiting activity of vanillin and guaiacol in macrophages stimulated with lipopolysaccharide. Anticancer Res 27:801-807. (Pubitemid 46586984)
30. Neurath MF, Fuss I, Kelsall BL, Stü ber E, and Strober W (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182:1281-1290.
31. Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Büschenfelde KH, Strober W, and Kollias G (1997) Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27:1743-1750.
32. Neurath MF, Pettersson S, Meyer zum Büschenfelde KH, and Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2:998-1004.
33. Opdyke DLJ (1977) Fragrance raw materials monographs. Vanillin. Food Cosmet Toxicol 15:633-638.
34. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, and Raedler A (1993) Enhanced secretion of tumour necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181. (Pubitemid 23308385)
35. Russel MG (2000) Changes in the incidence of inflammatory bowel disease: what does it mean? Eur J Intern Med 11:191-196. (Pubitemid 30680174)
36. Sands BE (2000) Therapy of inflammatory bowel disease. Gastroenterology 118:S68-S82.
37. Santosh Kumar SS, Priyadarsini KI, and Sainis KB (2004) Inhibition of peroxynitrite- mediated reactions by vanillin. J Agric Food Chem 52:139-145.
38. Schreiber S, Nikolaus S, and Hampe J (1998) Activation of nuclear factor-κB in inflammatory bowel disease. Gut 42:477-484. (Pubitemid 28186562)
39. Strober W, Fuss IJ, and Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20:495-549.
40. Wallace JL and Keenan CM (1990) An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 258:G527-G534.
41. Walton NJ, Mayer MJ, and Narbad A (2003) Vanillin. Phytochemistry 63:505-515.